CVS Group (CVSG)

Sector:

Retailers

Index:

FTSE AIM 50

 818.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 1,704.00p
  • 52 Week Low: 798.00p
  • Currency: UK Pounds
  • Shares Issued: 71.74m
  • Volume: 0
  • Market Cap: £586.83m
  • RiskGrade: 136
  • Beta: 0.01

CVS Group sales and EBITDA margins improve

By Iain Gilbert

Date: Wednesday 24 Nov 2021

LONDON (ShareCast) - (Sharecast News) - Veterinary services firm CVS Group said on Wednesday that its "positive start" to the new financial year had continued into September and October, with sales and margins increasing year-on-year.
CVS stated total sales had grown by 13.8% in the four months ended 31 October, while like-for-like sales increased 12.4% and adjusted underlying earnings margins remained "strong" at 19.2%, up from 18.7% at the same time a year earlier.

The AIM-listed group also noted that strong cash generation across its operations had continued since year-end and leverage on a bank test basis had remained "comfortably below 1.0x", in line with management expectations.

CVS added that it was focussed on investing in its practices, improving the facilities and expanding the offering of specialist facilities and clinical procedures in order to provide "the best possible care" to animals.

"The board considers that current trading is supportive of management's full-year expectations and the Group remains well placed to deliver further growth over the longer term; we look forward to sharing further updates as appropriate," said CVS.

As of 1050 GMT, CVS shares were down 0.99% at 2,401.0p.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

CVS Group Market Data

Currency UK Pounds
Share Price 818.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 1,704.00p
52 Week Low 798.00p
Volume 0
Shares Issued 71.74m
Market Cap £586.83m
Beta 0.01
RiskGrade 136

CVS Group Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
0.07% below the market average0.07% below the market average0.07% below the market average0.07% below the market average0.07% below the market average
17.95% below the sector average17.95% below the sector average17.95% below the sector average17.95% below the sector average17.95% below the sector average
Price Trend
70.09% below the market average70.09% below the market average70.09% below the market average70.09% below the market average70.09% below the market average
69.23% below the sector average69.23% below the sector average69.23% below the sector average69.23% below the sector average69.23% below the sector average
Income
87.25% below the market average87.25% below the market average87.25% below the market average87.25% below the market average87.25% below the market average
90% below the sector average90% below the sector average90% below the sector average90% below the sector average90% below the sector average
Growth
46.9% below the market average46.9% below the market average46.9% below the market average46.9% below the market average46.9% below the market average
23.08% below the sector average23.08% below the sector average23.08% below the sector average23.08% below the sector average23.08% below the sector average

What The Brokers Say

Strong Buy 4
Buy 4
Neutral 1
Sell 1
Strong Sell 0
Total 10
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

CVS Group Dividends

  Latest Previous
  Final Final
Ex-Div 31-Oct-24 02-Nov-23
Paid 29-Nov-24 08-Dec-23
Amount 8.00p 7.50p

Trades for --2025

Time Volume / Share Price
0 @ 0.000p

CVS Group Key Personnel

CEO Richard Fairman
Finance Director Robin Alfonso

Top of Page